Urodynamic Risk Factors for Recurrent Febrile Graft Pyelonephritis in Kidney Transplant Recipients: A Retrospective Study
LUTS: Lower Urinary Tract Symptoms · 2025
DOI: 10.1111/luts.70031 ↗Kurz gefasst
Fachartikel in der Zeitschrift LUTS: Lower Urinary Tract Symptoms, 2025. Verfasst von Jun Kamei und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Kidney Transplantation, Pyelonephritis, Urodynamics, Postoperative Complications. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: JSPS KAKENHI.
Abstract (Originalsprache)
Objectives
We aimed to assess lower urinary tract function and morphological changes in kidney transplant recipients with a history of graft pyelonephritis and investigate the association between specific types of lower urinary tract dysfunction and the risk of recurrent graft pyelonephritis.
Methods
We retrospectively reviewed the medical records of kidney transplant recipients hospitalized for febrile graft pyelonephritis more than 1 year after transplantation between April 2019 and October 2023. Patients underwent cystography and urodynamic studies after infection control and were followed up for at least 12 months. They were classified based on urodynamic findings, and recurrence‐free survival was analyzed.
Results
Twenty‐four patients were included. Vesicoureteral reflux of the grafted kidney was observed in 20 (83.3%) patients. Detrusor overactivity, detrusor underactivity, and low‐compliance bladders were diagnosed in 8 (33.3%), 12 (50.0%), and 7 (29.2%) patients, respectively. Based on urodynamic findings, treatment and bladder management were modified in 20 patients. During a median follow‐up of 33 months, seven patients developed recurrent graft pyelonephritis. Detrusor overactivity remained an independent risk factor for recurrent graft pyelonephritis (odds ratio, 21.4; p = 0.04). Patients with detrusor overactivity or underactivity but not low‐compliance bladder had significantly shorter recurrence‐free survival compared with those without these dysfunctions ( p = 0.017, 0.038, and 0.38, respectively).
Conclusions
Persistent lower urinary tract dysfunction, particularly detrusor overactivity, is a significant risk factor for recurrent graft pyelonephritis. Comprehensive evaluation of vesicoureteral reflux and lower urinary tract function via urodynamic studies is important to improve posttransplant outcomes in patients with a history of graft pyelonephritis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.
- Department of Urology, Jichi Medical University, Tochigi, Japan.
- Division of Renal Surgery and Transplantation, Department of Urology, Jichi Medical University, Tochigi, Japan.
ORCID-Profile: Jun Kamei, Takehiro Ohyama
Förderung
- JSPS KAKENHI
Zitieren
APA
Kamei, J., Takaoka, E. I., Ohyama, T., Nishida, S., Watanabe, D., Niimi, A., Yamada, Y., Sugihara, T., Ando, S., Kume, H., Iwami, D., & Fujimura, T. (2025). Urodynamic Risk Factors for Recurrent Febrile Graft Pyelonephritis in Kidney Transplant Recipients: A Retrospective Study. LUTS: Lower Urinary Tract Symptoms. https://doi.org/10.1111/luts.70031
Vancouver
Kamei J, Takaoka EI, Ohyama T, Nishida S, Watanabe D, Niimi A, et al. Urodynamic Risk Factors for Recurrent Febrile Graft Pyelonephritis in Kidney Transplant Recipients: A Retrospective Study. LUTS: Lower Urinary Tract Symptoms. 2025. doi:10.1111/luts.70031
BibTeX
@article{Kamei2025,
author = {Kamei, Jun and Takaoka, Ei-Ichiro and Ohyama, Takehiro and Nishida, Sho and Watanabe, Daiji and Niimi, Aya and Yamada, Yuta and Sugihara, Toru and Ando, Satoshi and Kume, Haruki and Iwami, Daiki and Fujimura, Tetsuya},
title = {Urodynamic Risk Factors for Recurrent Febrile Graft Pyelonephritis in Kidney Transplant Recipients: A Retrospective Study},
journal = {LUTS: Lower Urinary Tract Symptoms},
year = {2025},
doi = {10.1111/luts.70031}
}
EUVIMED